FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Jan van Hattum

Research Profile

Chemicals & Drugs

Disorders

Co-author Network

Publications

TOP 3
Francisca H H Linn; Roderick H J Houwen; Jan van Hattum; Stefan van der Kleij; Karel J van Erpecum
Long-term exclusive zinc monotherapy in symptomatic Wilson disease: experience in 17 patients.
Jane Zuckerman; Jan van Hattum; Mary Cafferkey; Ida Gjørup; Terje Hoel; Maija-Liisa Rummukainen; Ola Weiland
Should hepatitis B vaccination be introduced into childhood immunisation programmes in northern Europe?
Karel Jan Tusenius; Anne Marie Spoek; Jan van Hattum
Exploratory study on the effects of treatment with two mistletoe preparations on chronic hepatitis C.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Jan van Hattum (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2009: Francisca H H Linn; Roderick H J Houwen; Jan van Hattum; Stefan van der Kleij; Karel J van Erpecum
Long-term exclusive zinc monotherapy in symptomatic Wilson disease: experience in 17 patients.
Hepatology (Baltimore, Md.) 2009;50(5):1442-52.
2007: Jane Zuckerman; Jan van Hattum; Mary Cafferkey; Ida Gjørup; Terje Hoel; Maija-Liisa Rummukainen; Ola Weiland
Should hepatitis B vaccination be introduced into childhood immunisation programmes in northern Europe?
The Lancet infectious diseases 2007;7(6):410-9.
2005: Karel Jan Tusenius; Anne Marie Spoek; Jan van Hattum
Exploratory study on the effects of treatment with two mistletoe preparations on chronic hepatitis C.
Arzneimittel-Forschung 2005;55(12):749-53.
2004: Greet J Boland; Jiri Beran; M Lievens; J Sasadeusz; P Dentico; Hans D Nothdurft; J N Zuckerman; B Genton; R Steffen; L Loutan; Jan van Hattum; M Stoffel
Safety and immunogenicity profile of an experimental hepatitis B vaccine adjuvanted with AS04.
Vaccine 2004;23(3):316-20.
2004: Janneke M Stapelbroek; Casper W Bollen; Johannes K Ploos van Amstel; Karel J van Erpecum; Jan van Hattum; Leonard H van den Berg; Leo W J Klomp; Roderick H J Houwen
The H1069Q mutation in ATP7B is associated with late and neurologic presentation in Wilson disease: results of a meta-analysis.
Journal of hepatology 2004;41(5):758-63.
2004: Johannes T Brouwer; Frederik Nevens; Frank C Bekkering; Nadine Bourgeois; Hans Van Vlierberghe; Christine J Weegink; Véronique Lefebvre; Jan van Hattum; Jean Henrion; Jean Delwaide; Bettina E Hansen; Solko W Schalm
Reduction of relapse rates by 18-month treatment in chronic hepatitis C. A Benelux randomized trial in 300 patients.
Journal of hepatology 2004;40(4):689-95.
2004: Ru-Xiang Wang; Greet J Boland; Jan van Hattum; Gijsbert C De Gast
Long-term persistence of T cell memory to HBsAg after hepatitis B vaccination.
World journal of gastroenterology : WJG 2004;10(2):260-3.
2003: Ru-Xiang Wang; Greet J Boland; Ying Guo; Shao-Ping Lei; Chang-Hong Yang; Juan Chen; Jie Tian; Jin-Ying Wen; Ke-Hong Du; Jan van Hattum; Gijsbert C De Gast
Is a low dose of hepatitis B vaccine enough for a rapid vaccination scheme?
World journal of gastroenterology : WJG 2003;9(10):2353-5.
2003: Henk R van Buuren; Marijke C Rasch; Piet L Batenburg; Clemens J M Bolwerk; Jan J Nicolai; Sylvie van der Werf; Joost Scherpenisse; Lidia R Arends; Jan van Hattum; Erik A J Rauws; Solko W Schalm
Endoscopic sclerotherapy compared with no specific treatment for the primary prevention of bleeding from esophageal varices. A randomized controlled multicentre trial [ISRCTN03215899].
BMC gastroenterology 2003;3():22.
2003: Janneke M Stapelbroek; J K Ploos van Amstel; Jan van Hattum; L H van den Berg; Leo W J Klomp; Roderick H J Houwen
[From gene to disease; Wilson disease: copper storage due to mutations in ATP7B].
Nederlands tijdschrift voor geneeskunde 2003;147(13):603-5.
2003: Annemarie Sleijffers; Berran Yucesoy; Michael Kashon; Johan Garssen; Frank R de Gruijl; Greet J Boland; Jan van Hattum; Michael I Luster; Henk Van Loveren
Cytokine polymorphisms play a role in susceptibility to ultraviolet B-induced modulation of immune responses after hepatitis B vaccination.
Journal of immunology (Baltimore, Md. : 1950) 2003;170(6):3423-8.
2003: Annemarie Sleijffers; Arthur Kammeyer; Frank R de Gruijl; Greet J Boland; Jan van Hattum; Willem A van Vloten; Henk Van Loveren; Marcel B M Teunissen; Johan Garssen
Epidermal cis-urocanic acid levels correlate with lower specific cellular immune responses after hepatitis B vaccination of ultraviolet B-exposed humans.
Photochemistry and photobiology 2003;77(3):271-5.
2003: Hanneke van Soest; Jan van Hattum
New treatment options for chronic hepatitis C.
Advances in experimental medicine and biology 2003;531():219-26.
2003: Greet J Boland; Nynke Cnossen; Toon van Bommel; Annemarie Rulos-van den Berg; Jan-Paul van den Berg; Anton M van Loon; Jan van Hattum
Molecular diversity of hepatitis C virus in the Batam region.
Advances in experimental medicine and biology 2003;531():211-7.
2003: Juke R Saketi; Greet J Boland; Anton M van Loon; Jan van Hattum; Sitih A Abdurachman; Enday Sukandar
Prevalence of hepatitis C virus infection among haemodialysis patients in West Java, Indonesia.
Advances in experimental medicine and biology 2003;531():201-9.
2003: Greet J Boland; Toon van Bommel; Annemarie Rulos-van den Berg; Jan-Paul van den Berg; Anton M van Loon; Jan van Hattum
The efficacy of a two-dose hepatitis B vaccination scheme.
Advances in experimental medicine and biology 2003;531():185-90.
2003: Jan van Hattum; Greet J Boland; Karen G J J Jansen; Anouk S Kleinpenning; Toon van Bommel; Anton M van Loon; Sitih A Abdurachman; Hadi Yusuf; Annemarie Rulos-van den Berg; Jan van den Berg
Transmission profile of hepatitis B virus infection in the Batam region, Indonesia. Evidence for a predominantly horizontal transmission profile.
Advances in experimental medicine and biology 2003;531():177-83.
2003: K Vroonhof; H J M van Rijn; Jan van Hattum
Vitamin K deficiency and bleeding after long-term use of cholestyramine.
The Netherlands journal of medicine 2003;61(1):19-21.
2002: Berran Yucesoy; Annemarie Sleijffers; Michael Kashon; Johan Garssen; Frank R de Gruijl; Greet J Boland; Jan van Hattum; Petia P Simeonova; Michael I Luster; Henk Van Loveren
IL-1beta gene polymorphisms influence hepatitis B vaccination.
Vaccine 2002;20(25-26):3193-6.
2002: Annemarie Sleijffers; Johan Garssen; Frank R de Gruijl; Greet J Boland; Jan van Hattum; Willem A van Vloten; Henk Van Loveren
UVB exposure impairs immune responses after hepatitis B vaccination in two different mouse strains.
Photochemistry and photobiology 2002;75(5):541-6.
2002: Jan van Hattum
Health strategy on HCV in The Netherlands.
Acta gastro-enterologica Belgica 2002;65(2):115-7.
2002: Rudolf Heijtink; J Kruining; PF van Bergen; S de Rave; Jan van Hattum; Martin Schutten; A D M E Osterhaus
Characterization of a human monoclonal antibody obtained after immunization with plasma vaccine and a booster with recombinant-DNA hepatitis B vaccine.
Journal of medical virology 2002;66(3):304-11.
2001: Annemarie Sleijffers; Johan Garssen; Frank R de Gruijl; Greet J Boland; Jan van Hattum; Willem A van Vloten; Henk Van Loveren
Influence of ultraviolet B exposure on immune responses following hepatitis B vaccination in human volunteers.
The Journal of investigative dermatology 2001;117(5):1144-50.
2001: Harry L A Janssen; A Wijnhoud; Elizabeth B Haagsma; S H van Uum; Carin M J van Nieuwkerk; R P Adang; Robert Chamuleau; Jan van Hattum; Frank P Vleggaar; Bettina E Hansen; F R Rosendaal; Bart van Hoek
Extrahepatic portal vein thrombosis: aetiology and determinants of survival.
Gut 2001;49(5):720-4.
2001: Hanneke van Soest; Jan van Hattum
Treatment of chronic hepatitis C: lessons from human immunodeficiency virus dynamics.
Scandinavian journal of gastroenterology. Supplement 2001;(234):93-7.
2000: Harry L A Janssen; J R Meinardi; Frank P Vleggaar; S H van Uum; Elizabeth B Haagsma; F J van Der Meer; Jan van Hattum; Robert Chamuleau; R P Adang; J P Vandenbroucke; Bart van Hoek; Frits R Rosendaal
Factor V Leiden mutation, prothrombin gene mutation, and deficiencies in coagulation inhibitors associated with Budd-Chiari syndrome and portal vein thrombosis: results of a case-control study.
Blood 2000;96(7):2364-8.
2000: HJ van Hoogstraten; Frank P Vleggaar; G J Boland; W van Steenbergen; P Griffioen; WC Hop; Jan van Hattum; Gerard P van Berge-Henegouwen; Solko W Schalm; Henk R van Buuren
Budesonide or prednisone in combination with ursodeoxycholic acid in primary sclerosing cholangitis: a randomized double-blind pilot study. Belgian-Dutch PSC Study Group.
The American journal of gastroenterology 2000;95(8):2015-22.
2000: F ter Borg; Fiebo J W Ten Kate; H Theo M Cuypers; A Leentvaar-Kuijpers; Johannes Oosting; Pauline M E Wertheim-van Dillen; Pieter Honkoop; Marijke C Rasch; Robert A de Man; Jan van Hattum; Robert Chamuleau; G N J Tytgat; E Anthony Jones
A survey of liver pathology in needle biopsies from HBsAg and anti-HBe positive individuals.
Journal of clinical pathology 2000;53(7):541-8.
2000: Marjolein van Egmond; Evert van Garderen; Annemiek van Spriel; CA Damen; Edwin S Van Amersfoort; Ger van Zandbergen; Jan van Hattum; Johan Kuiper; Jan G J van de Winkel
FcalphaRI-positive liver Kupffer cells: reappraisal of the function of immunoglobulin A in immunity.
Nature medicine 2000;6(6):680-5.
1999: Jan van Hattum; X Q Chen
Hepatitis A: infection, detection, vaccination and immunity.
The Netherlands journal of medicine 1999;55(3):142-50.
1999: Harry L A Janssen; G Gerken; V Carreño; P Marcellin; Nikolai Naoumov; A Craxi; H Ring-Larsen; G Kitis; Jan van Hattum; Richard A de Vries; Peter P Michielsen; Fiebo J W Ten Kate; Wim C J Hop; Rudolf Heijtink; Pieter Honkoop; Solko W Schalm
Interferon alfa for chronic hepatitis B infection: increased efficacy of prolonged treatment. The European Concerted Action on Viral Hepatitis (EUROHEP).
Hepatology (Baltimore, Md.) 1999;30(1):238-43.
1999: John M Jongerius; G Boland; Cees L van der Poel; Marijke C Rasch; E Italiaander; J van der Reijden; Paula Friedman; J Cockerill; EF van Leeuwen; Jan van Hattum
GB virus type C viremia and envelope antibodies among population subsets in The Netherlands.
Vox sanguinis 1999;76(2):81-4.
1998: Marijke C Rasch; H Schellekens; C M van Dijck; E B Haagsma; Peter P Michielsen; A H van Buuren; H Stötter; Jan van Hattum
Tolerance and antiviral effects of high-dose interferon-alpha B/D in patients with chronic hepatitis B.
Digestive diseases and sciences 1998;43(8):1719-24.
1998: F ter Borg; Fiebo J W Ten Kate; H Theo M Cuypers; A Leentvaar-Kuijpers; Johannes Oosting; Pauline M E Wertheim-van Dillen; Pieter Honkoop; Marijke C Rasch; Robert A de Man; Jan van Hattum; Robert Chamuleau; Henk W Reesink; E Anthony Jones
Relation between laboratory test results and histological hepatitis activity in individuals positive for hepatitis B surface antigen and antibodies to hepatitis B e antigen.
Lancet 1998;351(9120):1914-8.
1998: Karin Jorga; J M Kroodsma; B Fotteler; P Heizmann; J Meyer; Marijke C Rasch; Jan van Hattum
Effect of liver impairment on the pharmacokinetics of tolcapone and its metabolites.
Clinical pharmacology and therapeutics 1998;63(6):646-54.
1997: Richard J Sinke; Victoria E H Carlton; Jenneke A Juijn; T Delhaas; Laura N Bull; Gerard P van Berge-Henegouwen; Jan van Hattum; K M Keller; Maarten Sinaasappel; C M Bijleveld; I E Knol; H K Ploos van Amstel; Peter L Pearson; Ruud Berger; Nelson B Freimer; Roderick H J Houwen
Benign recurrent intrahepatic cholestasis (BRIC): evidence of genetic heterogeneity and delimitation of the BRIC locus to a 7-cM interval between D18S69 and D18S64.
Human genetics 1997;100(3-4):382-7.
1997: X Q Chen; M Bülbül; Gijsbert C De Gast; Anton M van Loon; D R Nalin; Jan van Hattum
Immunogenicity of two versus three injections of inactivated hepatitis A vaccine in adults.
Journal of hepatology 1997;26(2):260-4.
1996: PC van de Meeberg; FH Wolfhagen; Gerard P van Berge-Henegouwen; J M Salemans; Albert Tangerman; Henk R van Buuren; Jan van Hattum; Karel J van Erpecum
Single or multiple dose ursodeoxycholic acid for cholestatic liver disease: biliary enrichment and biochemical response.
Journal of hepatology 1996;25(6):887-94.
1995: Peter de Vries; P de Hooge; J B L Hoekstra; Jan van Hattum
Postprandial reversal of the portal venous flow in a patient with liver cirrhosis.
The Netherlands journal of medicine 1995;47(5):235-40.
1995: FH Wolfhagen; Henk R van Buuren; Solko W Schalm; Fiebo J W Ten Kate; Jan van Hattum; F A Eskens; J W den Ouden Muller; R A de Vries; J Ferwerda; E W van der Hoek
Can ursodeoxycholic acid induce disease remission in primary biliary cirrhosis? The Dutch Multicentre PBC Study Group.
Journal of hepatology 1995;22(3):381.
1995: H N van Wassenaer-van Hall; Jeroen van der Grond; Jan van Hattum; C Kooijman; T U Hoogenraad; W P Th M Mali
31P magnetic resonance spectroscopy of the liver: correlation with standardized serum, clinical, and histological changes in diffuse liver disease.
Hepatology (Baltimore, Md.) 1995;21(2):443-9.
1995: JC Koningsberger; L H Rademakers; Jan van Hattum; H B de la Faille; L J Wiegman; E Italiaander; Gerard P van Berge-Henegouwen; Joannes Marx
Exogenous protoporphyrin inhibits Hep G2 cell proliferation, increases the intracellular hydrogen peroxide concentration and causes ultrastructural alterations.
Journal of hepatology 1995;22(1):57-65.
1994: Peter de Vries; P de Hooge; J B L Hoekstra; Jan van Hattum
Blunted postprandial reaction of portal venous flow in chronic liver disease, assessed with duplex Doppler: significance for prognosis.
Journal of hepatology 1994;21(6):966-73.
1994: JC Koningsberger; B Sweder van Asbeck; E van Faassen; L J Wiegman; Jan van Hattum; Gerard P van Berge-Henegouwen; Joannes Marx
Copper, zinc-superoxide dismutase and hydrogen peroxide: a hydroxyl radical generating system.
Clinica chimica acta; international journal of clinical chemistry 1994;230(1):51-61.
1994: L Meerman; R Verwer; Maarten J H Slooff; Jan van Hattum; G J Beukeveld; J H Kleibeuker; Elizabeth B Haagsma
Perioperative measures during liver transplantation for erythropoietic protoporphyria.
Transplantation 1994;57(1):155-8.
1993: JC Koningsberger; B Sweder van Asbeck; Jan van Hattum; L J Wiegman; Gerard P van Berge-Henegouwen; Joannes Marx
The effect of porphyrins on cellular redox systems: a study on the dark effect of porphyrins on phagocytes.
European journal of clinical investigation 1993;23(11):716-23.
1993: Roderick H J Houwen; Jan van Hattum; T U Hoogenraad
Wilson disease.
The Netherlands journal of medicine 1993;43(1-2):26-37.
1993: leo10noor Wismans; Jan van Hattum
Strategies for hepatitis B infection.
Gut 1993;34(4):575.
1993: L H Rademakers; JC Koningsberger; C W Sorber; H Baart de la Faille; Jan van Hattum; Joannes Marx
Accumulation of iron in erythroblasts of patients with erythropoietic protoporphyria.
European journal of clinical investigation 1993;23(2):130-8.
1992: J C Bijlmer-Iest; H Baart de la Faille; B Sweder van Asbeck; Jan van Hattum; Huib van Weelden; Joannes Marx; JC Koningsberger
Protoporphyrin photosensitivity cannot be attenuated by oral N-acetylcysteine.
Photodermatology, photoimmunology & photomedicine 1992;9(6):245-9.
1992: K Paul Bouter; R J A Diepersloot; leo10noor Wismans; F H Gmelig Meyling; J B L Hoekstra; R A Heijtink; Jan van Hattum
Humoral immune response to a yeast-derived hepatitis B vaccine in patients with type 1 diabetes mellitus.
Diabetic medicine : a journal of the British Diabetic Association 1992;9(1):66-9.
1991: leo10noor Wismans; Jan van Hattum; Gijsbert C De Gast; K Paul Bouter; R J A Diepersloot; T Maikoe; Geert Mudde
A prospective study of in vitro anti-HBs producing B cells (spot-ELISA) following primary and supplementary vaccination with a recombinant hepatitis B vaccine in insulin dependent diabetic patients and matched controls.
Journal of medical virology 1991;35(3):216-22.
1991: Peter de Vries; Jan van Hattum; J B L Hoekstra; P de Hooge
Duplex Doppler measurements of portal venous flow in normal subjects. Inter- and intra-observer variability.
Journal of hepatology 1991;13(3):358-63.
1991: L H Rademakers; M I Cleton; C Kooijman; H Baart de la Faille; Jan van Hattum
Ultrastructural aspects of the liver in erythrohepatic protoporphyria.
Current problems in dermatology 1991;20():154-9.
1991: H Baart de la Faille; J C Bijlmer-Iest; Jan van Hattum; JC Koningsberger; L H Rademakers; Huib van Weelden
Erythropoietic protoporphyria: clinical aspects with emphasis on the skin.
Current problems in dermatology 1991;20():123-34.
1990: L H Rademakers; M I Cleton; C Kooijman; H Baart de la Faille; Jan van Hattum
Early involvement of hepatic parenchymal cells in erythrohepatic protoporphyria? An ultrastructural study of patients with and without overt liver disease and the effect of chenodeoxycholic acid treatment.
Hepatology (Baltimore, Md.) 1990;11(3):449-57.
1989: leo10noor Wismans; Jan van Hattum; Gijsbert C De Gast; H J Endeman; J Poel; B Stolk; T Maikoe; Geert Mudde
The spot-ELISA: a sensitive in vitro method to study the immune response to hepatitis B surface antigen.
Clinical and experimental immunology 1989;78(1):75-9.
1989: leo10noor Wismans; Jan van Hattum; Geert Mudde; H J Endeman; J Poel; Gijsbert C De Gast
Is booster injection with hepatitis B vaccine necessary in healthy responders? A study of the immune response.
Journal of hepatology 1989;8(2):236-40.
1988: H J van Wijk; Jan van Hattum; H Baart de la Faille; J Willem O van den Berg; A Edixhoven-Bosdijk; J H Paul Wilson
Blood exchange and transfusion therapy for acute cholestasis in protoporphyria.
Digestive diseases and sciences 1988;33(12):1621-5.
1988: T U Hoogenraad; Jan van Hattum
Zinc therapy as the initial treatment for Wilson's disease.
Archives of neurology 1988;45(4):373-4.
1988: P Wismans; Jan van Hattum; T Stelling; J Poel; Gijsbert C De Gast
Effect of supplementary vaccination in healthy non-responders to hepatitis B vaccination.
Hepato-gastroenterology 1988;35(2):78-9.
1987: T U Hoogenraad; Jan van Hattum
[Treatment of Wilson's disease].
Deutsche medizinische Wochenschrift (1946) 1987;112(23):942-3.
1987: T U Hoogenraad; Jan van Hattum; C J Van den Hamer
Management of Wilson's disease with zinc sulphate. Experience in a series of 27 patients.
Journal of the neurological sciences 1987;77(2-3):137-46.
1986: Jan van Hattum; H Baart de la Faille; J Willem O van den Berg; A Edixhoven-Bosdijk; J H Paul Wilson
Chenodeoxycholic acid therapy in erythrohepatic protoporphyria.
Journal of hepatology 1986;3(3):407-12.
1985: T U Hoogenraad; Jan van Hattum
Unithiol in Wilson's disease.
British medical journal (Clinical research ed.) 1985;290(6476):1213.
1984: T Stelling; Jan van Hattum; G C de Gast
[Hepatitis B vaccination of hospital personnel].
Nederlands tijdschrift voor geneeskunde 1984;128(37):1753-7.
1984: T U Hoogenraad; C J Van den Hamer; Jan van Hattum
Effective treatment of Wilson's disease with oral zinc sulphate: two case reports.
British medical journal (Clinical research ed.) 1984;289(6440):273-6.